[1] |
GAIESKI DF, EDWARDS JM, KALLAN MJ, et al.Benchmarking the incidence and mortality of severe sepsis in the United States[J]. Crit Care Med, 2013, 41(5):1167-1174.
|
[2] |
GUSTOT T.Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response[J]. Curr Opin Crit Care, 2011, 17(2):153-159.
|
[3] |
LI L, ZHU Z, CHEN J, et al.Diagnostic value of soluble triggering receptor expressed on myeloid cells-1 in critically-ill, postoperative patients with suspected sepsis[J]. Am J Med Sci, 2013, 345(3):178-184.
|
[4] |
ABDOLLAHI A, SHOAR S, NAYYERI F, et al.Diagnostic value of simultaneous measurement of procalcitonin, interleukin-6 and hs-CRP in prediction of early-onset neonatal sepsis[J]. Mediterr J Hematol Infect Dis, 2012, 4(1):e2012028.
|
[5] |
UUSITALO-SEPPÄLÄ R, KOSKINEN P, LEINO A, et al. Early detection of severe sepsis in the emergency room: diagnostic value of plasma C-reactive protein, procalcitonin, and interleukin-6[J]. Scand J Infect Dis, 2011, 43(11-12):883-890.
|
[6] |
SRISANGTHONG P, WONGSA A, KITTIWORAWITKUL P, et al.Early IL-6 response in sepsis is correlated with mortality and severity score[J]. Crit Care, 2013, 17(Suppl 2):334-339.
|
[7] |
SHERWIN C, BROADBENT R, YOUNG S, et al.Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis[J]. Am J Perinatol, 2008, 25(10):629-636.
|
[8] |
SONG R, KIM J, YU D, et al.Kinetics of IL-6 and TNF-α changes in a canine model of sepsis induced by endotoxin[J]. Vet Immunol Immunopathol, 2012, 146(2):143-149.
|
[9] |
PACHOT A, MONNERET G, VOIRIN N, et al.Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock[J]. Clin Immunol, 2005, 114(1):61-99.
|
[10] |
SCICLUNA BP, VAN DER POLL T. Interleukin-27: a potential new sepsis biomarker exposed through genome-wide transcriptional profiling[J]. Crit Care, 2012, 16(6):188.
|
[11] |
WONG HR, CVIJANOVICH NZ, HALL M, et al.Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children[J]. Crit Care, 2012, 16(5):R213.
|
[12] |
LIU HL, LIU GH, MA QB.Value of procalcitonin in the early diagnosis of sepsis in department of emergency[J]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2012, 24(5):298-301.
|
[13] |
赵玉玲. 降钙素原对脓毒症早期诊断的临床意义[J]. 检验医学, 2006,21(4):431.
|
[14] |
RAJKUMARI N, MATHUR P, SHARMA S, et al.Procalcitonin as a predictor of sepsis and outcome in severe trauma patients: a prospective study[J]. J Lab Physicians, 2013, 5(2):100-108.
|
[15] |
TIAN G, PAN SY, MA G, et al.Serum levels of procalcitonin as a biomarker for differentiating between sepsis and systemic inflammatory response syndrome in the neurological intensive care unit[J]. J Clin Neurosci, 2014, 21(7):1153-1158.
|
[16] |
ZAHAR JR, TIMSIT JF, GARROUSTE-ORGEAS M, et al.Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality[J]. Crit Care Med, 2011, 39(8):1886-1895.
|
[17] |
KATAGIRI D, DOI K, MATSUBARA T, et al.New biomarker panel of plasma neutrophil gelatinase-associated lipocalin and endotoxin activity assay for detecting sepsis in acute kidney injury[J]. J Crit Care, 2013, 28(5):564-570.
|
[18] |
SHIMIZU T, OBATA T, SONODA H, et al.Diagnostic potential of endotoxin scattering photometry for sepsis and septic shock[J]. Shock, 2013, 40(6):504-511.
|
[19] |
WANG HE, SHAPIRO NI, GRIFFIN R, et al.Inflammatory and endothelial activation biomarkers and risk of sepsis: a nested case-control study[J]. J Crit Care, 2013, 28(5):549-555.
|
[20] |
刘德贝, 曹艳林, 邹飞扬, 等. 超敏CRP、IL-6及PCT对新生儿脓毒症早期诊断的意义[J]. 国际检验医学杂志, 2010,31(3):212-213.
|
[21] |
ARNON S, LITMANOVITZ I, REGEV R, et al.Serum amyloid A protein is a useful inflammatory marker during late-onset sepsis in preterm infants[J]. Biol Neonate, 2005, 87(2):105-110.
|
[22] |
FENDLER WM, PIOTROWSKI AJ.Procalcitonin in the early diagnosis of nosocomial sepsis in preterm neonates[J]. J Paediatr Child Health, 2008, 44(3):114-118.
|
[23] |
YUAN H, HUANG J, LV B, et al.Diagnosis value of the serum amyloid A test in neonatal sepsis: a meta-analysis[J]. Biomed Res Int, 2013, 2013:520294.
|
[24] |
CHEW MS, LINDER A, SANTEN S, et al.Increased plasma levels of heparin-binding protein in patients with shock: a prospective, cohort study[J]. Inflamm Res, 2012, 61(4):375-379.
|
[25] |
LINDER A, AKESSON P, INGHAMMAR M, et al.Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock[J]. Crit Care, 2012, 16(3):R90.
|
[26] |
LINDER A, CHRISTENSSON B, HERWALD H, et al.Heparin-binding protein: an early marker of circulatory failure in sepsis[J]. Clin Infect Dis, 2009, 49(7):1044-1050.
|
[27] |
SHANE AL, STOLL BJ.Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis[J]. Am J Perinatol, 2013, 30(2):131-141.
|
[28] |
POSTERARO B, DE PASCALE G, TUMBARELLO M, et al.Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of(1→ 3)-β-D-glucan assay, Candida score, and colonization index[J]. Crit Care, 2011, 15(5):R224.
|